I guess what you need to ask yourself is a. Are they moving forward? Yes they are albeit slowly IMO, but there have been no major set backs in fact being able to use less peptides is a very good thing making the test easier to do. I believe this has largely been overlooked IMO. b. If the test is independently validated then how much is an accurate blood test for Ovarian, Breast and Lung cancer worth? There currently are none. IMO once Ovarian is independently verified then breast will follow quickly behind then Lung. By the end of next year we could have 3 tests on the books. Given the hundreds of billions that would have been spent on Lung cancer alone I imagine 2.5 billion is certainly not out of the question. IF it were to all come off, and they are still moving the ball forward, then BD1 IMO will be a great investment and save thousands of lives.
BD1 Price at posting:
2.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)